Literature DB >> 21035576

Antibacterial activity of bone allografts: comparison of a new vancomycin-tethered allograft with allograft loaded with adsorbed vancomycin.

Constantinos Ketonis1, Stephanie Barr, Irving M Shapiro, Javad Parvizi, Christopher S Adams, Noreen J Hickok.   

Abstract

Bacterial contamination of bone allograft is a significant complication of orthopedic surgery. To address this issue, we have engineered a method for covalently modifying bone allograft tissue with the antibiotic vancomycin. The goal of this investigation was to compare the biocidal properties of this new allograft material with those of vancomycin physisorbed onto graft material. The duration of antibiotic release from the vancomycin-modified allograft matrix was determined, and no elution was observed. In contrast, the adsorbed antibiotic showed a peak elution at 24h that then decreased over several days. We next used an Staphylococcus aureus disk diffusion assay to measure the activity of the eluted vancomycin. Again we found that no active antibiotic was eluted from the covalently modified allograft. Similarly, when the vancomycin-modified allograft morsel was used in the assay, no measurable elution was observed; amounts of antibiotic released from the adsorbed samples inhibited S. aureus growth for 4-7 days. Probably the most telling property of the allograft was that after 2 weeks, the tethered allograft was able to resist bacterial colonization. Unlike the elution system in which vancomycin was depleted over the course of days-weeks, the antibiotic on the allograft was stably bound even after 300 days, while its biocidal activity remained undiminished for 60 days. This finding was in stark contrast to the antibiotic impregnated allograft, which was readily colonized by bacteria. Finally we chose to evaluate three indicators of cell function: expression of a key transcription factor, expression of selected transcripts, and assessment of cell morphology. Since the tethered antibiotic appeared to have little or no effect on any of these activities, it was concluded that the stable, tethered antibiotic prevented bacterial infection while not modifying bone cell function.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21035576      PMCID: PMC3039041          DOI: 10.1016/j.bone.2010.10.171

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  32 in total

1.  Bacterial colonization of bone allografts: establishment and effects of antibiotics.

Authors:  Constantinos Ketonis; Stephanie Barr; Christopher S Adams; Noreen J Hickok; Javad Parvizi
Journal:  Clin Orthop Relat Res       Date:  2010-08       Impact factor: 4.176

2.  Infection in bone allografts. Incidence, nature, and treatment.

Authors:  C F Lord; M C Gebhardt; W W Tomford; H J Mankin
Journal:  J Bone Joint Surg Am       Date:  1988-03       Impact factor: 5.284

3.  Natural history of autografts and allografts.

Authors:  V M Goldberg; S Stevenson
Journal:  Clin Orthop Relat Res       Date:  1987-12       Impact factor: 4.176

4.  Frozen musculoskeletal allografts. A study of the clinical incidence and causes of infection associated with their use.

Authors:  W W Tomford; J Thongphasuk; H J Mankin; M J Ferraro
Journal:  J Bone Joint Surg Am       Date:  1990-09       Impact factor: 5.284

5.  Biomaterial-associated infection of gentamicin-loaded PMMA beads in orthopaedic revision surgery.

Authors:  D Neut; H van de Belt; I Stokroos; J R van Horn; H C van der Mei; H J Busscher
Journal:  J Antimicrob Chemother       Date:  2001-06       Impact factor: 5.790

Review 6.  Clinical use of bone allografts.

Authors:  H T Aro; A J Aho
Journal:  Ann Med       Date:  1993-08       Impact factor: 4.709

Review 7.  Systemic and local regulation of the growth plate.

Authors:  B C J van der Eerden; M Karperien; J M Wit
Journal:  Endocr Rev       Date:  2003-12       Impact factor: 19.871

8.  Reconstruction for defects of the proximal part of the femur using allograft arthroplasty.

Authors:  M H Jofe; M C Gebhardt; W W Tomford; H J Mankin
Journal:  J Bone Joint Surg Am       Date:  1988-04       Impact factor: 5.284

9.  A study of the clinical incidence of infection in the use of banked allograft bone.

Authors:  W W Tomford; R J Starkweather; M H Goldman
Journal:  J Bone Joint Surg Am       Date:  1981-02       Impact factor: 5.284

10.  Clinical experience with allograft implantation. The first ten years.

Authors:  H J Mankin; S Doppelt; W Tomford
Journal:  Clin Orthop Relat Res       Date:  1983-04       Impact factor: 4.176

View more
  12 in total

1.  Vancomycin bonded to bone grafts prevents bacterial colonization.

Authors:  Constantinos Ketonis; Stephanie Barr; Christopher S Adams; Irving M Shapiro; Javad Parvizi; Noreen J Hickok
Journal:  Antimicrob Agents Chemother       Date:  2010-11-22       Impact factor: 5.191

2.  Polymer-controlled release of tobramycin from bone graft void filler.

Authors:  Amanda E Brooks; Benjamin D Brooks; Sherry N Davidoff; Paul C Hogrebe; Mark A Fisher; David W Grainger
Journal:  Drug Deliv Transl Res       Date:  2013-12       Impact factor: 4.617

3.  Polyglutamate directed coupling of bioactive peptides for the delivery of osteoinductive signals on allograft bone.

Authors:  Bonnie K Culpepper; Paul P Bonvallet; Michael S Reddy; Selvarangan Ponnazhagan; Susan L Bellis
Journal:  Biomaterials       Date:  2012-11-23       Impact factor: 12.479

4.  Tetracycline tethered to titanium inhibits colonization by Gram-negative bacteria.

Authors:  Helen Davidson; Martin Poon; Ray Saunders; Irving M Shapiro; Noreen J Hickok; Christopher S Adams
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2014-11-12       Impact factor: 3.368

5.  Modification of human cancellous bone using Thai silk fibroin and gelatin for enhanced osteoconductive potential.

Authors:  Rungnapa Vorrapakdee; Sorada Kanokpanont; Juthamas Ratanavaraporn; Saranatra Waikakul; Chris Charoenlap; Siriporn Damrongsakkul
Journal:  J Mater Sci Mater Med       Date:  2012-12-08       Impact factor: 3.896

6.  An anti-infection tissue-engineered construct delivering vancomycin: its evaluation in a goat model of femur defect.

Authors:  Zhengqi Chang; Tianyong Hou; Xuehui Wu; Fei Luo; Junchao Xing; Zhiqiang Li; Qianbo Chen; Bo Yu; Jianzhong Xu; Zhao Xie
Journal:  Int J Med Sci       Date:  2013-10-15       Impact factor: 3.738

7.  Increased release time of antibiotics from bone allografts through a novel biodegradable coating.

Authors:  István Hornyák; Edit Madácsi; Pálma Kalugyer; Gabriella Vácz; Dénes B Horváthy; Miklós Szendrői; Weiping Han; Zsombor Lacza
Journal:  Biomed Res Int       Date:  2014-06-19       Impact factor: 3.411

8.  A resorbable antibiotic-eluting polymer composite bone void filler for perioperative infection prevention in a rabbit radial defect model.

Authors:  Benjamin D Brooks; Kristofer D Sinclair; David W Grainger; Amanda E Brooks
Journal:  PLoS One       Date:  2015-03-27       Impact factor: 3.240

9.  Ultrasound-triggered antibiotic release from PEEK clips to prevent spinal fusion infection: Initial evaluations.

Authors:  Lauren J Delaney; Daniel MacDonald; Jay Leung; Keith Fitzgerald; Alex M Sevit; John R Eisenbrey; Neil Patel; Flemming Forsberg; Christopher K Kepler; Taolin Fang; Steven M Kurtz; Noreen J Hickok
Journal:  Acta Biomater       Date:  2019-02-28       Impact factor: 8.947

10.  Biomimetic delivery of signals for bone tissue engineering.

Authors:  Ming Dang; Laura Saunders; Xufeng Niu; Yubo Fan; Peter X Ma
Journal:  Bone Res       Date:  2018-08-29       Impact factor: 13.567

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.